Helical tomotherapy with concurrent capecitabine for the treatment of inoperable pancreatic cancer

Radiation Oncology

Table 4 Clinical outcomes in the nineteen patients treated with tomotherapy and concurrent capecitabine

Patient	Overall In-field tumor response	Duration of tumor response (months)	Treatment-related toxicity	Duration of follow-up after tomotherapy (months)	Out-field progression state	Cause of death other than cancer progression	Duration of survival after tomotherapy (months)
1	Stable disease	5.9	fatigue (grade 2)	7.3	Progressed		7.3
2	Partial response		hand foot syndrome (grade 1)	3.2			4.8
3	Stable disease			10.7			11.2
4	Stable disease	3.8		5.8	Progressed		5.8
5				1.1		Pneumonia	1.1
6	Partial response		fatigue (grade 2)	6.8			13.9
7	Stable disease	6.9		15	Progressed		16.3
8				1.8			1.9
9	Partial response	2.4	nausea (grade 1)	4.4	Progressed		4.4
10	Partial response			13.6			13.9
11	Stable disease	4.1	fatigue (grade 1)	4.1	Stable disease	Pulmonary thromboembolism	4.1
12	Stable disease	2.2		3.4	Progressed		3.9
13	Stable disease	2.5		6.5	Progressed		6.5
14				2		DUB, Pneumonia	2
15	Stable disease			10.5			10.5
16	Partial response	7.3		7.3	Stable disease	Pneumonia	7.3
17	Partial response			14.9			18.4
18	Partial response			17.6			21
19	Partial response	3.2		6.2	Progressed		6.5

ISSN: 1748-717X